E. LALOĞLU And H. ALAY, "Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR," UPSALA JOURNAL OF MEDICAL SCIENCES , vol.127, no.1, 2022
LALOĞLU, E. And ALAY, H. 2022. Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR. UPSALA JOURNAL OF MEDICAL SCIENCES , vol.127, no.1 .
LALOĞLU, E., & ALAY, H., (2022). Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR. UPSALA JOURNAL OF MEDICAL SCIENCES , vol.127, no.1.
LALOĞLU, Esra, And Handan ALAY. "Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR," UPSALA JOURNAL OF MEDICAL SCIENCES , vol.127, no.1, 2022
LALOĞLU, Esra And ALAY, Handan. "Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR." UPSALA JOURNAL OF MEDICAL SCIENCES , vol.127, no.1, 2022
LALOĞLU, E. And ALAY, H. (2022) . "Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR." UPSALA JOURNAL OF MEDICAL SCIENCES , vol.127, no.1.
@article{article, author={Esra LALOĞLU And author={Handan ALAY}, title={Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR}, journal={UPSALA JOURNAL OF MEDICAL SCIENCES}, year=2022}